Evidence map›Paper›PMID 31680964›Full record

ArticleFrontiers in pharmacology2019

Cytokines Driven Anti-Inflammatory and Anti-Psoriasis Like Efficacies of Nutraceutical Sea Buckthorn (

Acharya Balkrishna, Sachin Shridhar Sakat, Kheemraj Joshi, Kamal Joshi, Vinay Sharma, Ravikant Ranjan, Kunal Bhattacharya, Anurag Varshney

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Sea Buckthorn (Foods (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
  7. Effects of a NovelJournal of cardiovascular development and disease · 2025
    Article
  8. Beneficial effects ofPharmaceutical biology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Experimental research in topical psoriasis therapy (Review).Experimental and therapeutic medicine · 2021
    Review
  17. Nanonutraceuticals: The New Frontier of Supplementary Food.Nanomaterials (Basel, Switzerland) · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Acharya BalkrishnaDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Sachin Shridhar SakatDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Kheemraj JoshiDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Kamal JoshiDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Vinay SharmaDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Ravikant RanjanDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Kunal BhattacharyaDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Anurag VarshneyDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, India.
Patanjali Research Foundation · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by circumscribed, red, thickened plaques with overlying silvery white scales. It is associated with the release of pro-inflammatory mediators that lead to the development of edema and distress. Here we show the anti-inflammatory and anti-psoriatic efficacies of a neutraceutical sea buckthorn oil (SBKT) derived from the fruit pulp of

Indexed as

12-O-tetradecanoyl phorbol-13-acetateanti-inflammatory activitycytokinesnutraceuticalpaw edemapsoriasissea buckthorn oilTHP-1

Identifiers

PMID31680964
PMCPMC6797847
OpenAlexW2979979070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.